Rinri Therapeutics Raises £10M From Existing Investors And Uk Future Fund To Advance Its Novel Stem Cell Therapy To Restore Hearing Loss

by prnewswire.com posted 5months ago 153 views
SHEFFIELD, England, April 20, 2021 /PRNewswire/ -- Rinri Therapeutics, a biotechnology company developing a novel stem cell therapy to restore hearing, today announces that it has raised a total of £10 million from existing investors Boehringer Ingelheim Venture Fund (BIVF), UCB Ventures...

In this article